While the dynamics and significance of serum levels of GFAP is not well understood, GFAP is considered the archetypal marker of reactive astrocytes,26, 27 which are now understood to encompass spectrum of phenotypes both deleterious and beneficial in MS.28 The gene discussed is GFAP; the disease is myeloid sarcoma.